What top creators are saying about ER-100(ER-100)
Investigational therapy being studied for restoring gene expression in certain eye conditions
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Based on 1 scored insight about ER-100.
Top creators covering ER-100 (ER-100)
The 1 sources with the most insights about ER-100 on Kazuha.
Latest insights about ER-100 (ER-100)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Today
Described as being in a Phase 1 safety trial and as a potential approach to restoring gene expression; trial outcomes and commercial prospects remain uncertain.
Today
Described as being in a Phase 1 safety trial and as a potential approach to restoring gene expression; trial outcomes and commercial prospects remain uncertain.
Discussed alongside ER-100 (ER-100)
Other assets that creators frequently mention in the same content as ER-100.
Frequently asked
Which podcasters and creators cover ER-100 (ER-100) the most?
The most active sources covering ER-100 (ER-100) on Kazuha are PHD Ventures. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about ER-100 (ER-100) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about ER-100 (ER-100) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside ER-100 (ER-100)?
Creators covering ER-100 (ER-100) most frequently also discuss GOOGL, AMZN, PRIVATE, META, PARTHAM. See the "Discussed alongside" section above for full asset pages.